United States Specialty Generics Market 2024: A Valuation of US$ 57.94 Billion Predicted by 2032 | IMARC Group
IMARC Group, a leading market research company, has recently releases report titled “ United States Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Therapeutic Application (Oncology, Hepatitis, Multiple Sclerosis, HIV, Other Autoimmune Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies) 2024-2032 ”. The study provides a detailed analysis of the industry, including the United States specialty generics market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. How Big is the United States Specialty Generics Market? The United States specialty generics market size reached US$ 26.09 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.94 Billion by 2032, exhibiting a growth rate (CAGR) of 9% during 2024-2032. Request to Get the Sample Report: https://www.imarcgr